Growth Opportunities and Trends in the Genome Editing/Genome Engineering Market: Key Insights for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the CAGR of the Genome Editing/Genome Engineering Market Influence Its Overall Growth by 2034?
The market size for genome editing/genome engineering has experienced rapid expansion in the last few years. An upswing from $8.62 billion in 2024 to $10.2 billion in 2025 is expected, reflecting a compound annual growth rate (CAGR) of 18.2%. This significant growth during the historical period is largely due to progressive research in genetics and genomics, the increase in genetic diseases, advancements in gene therapy, investment growth in biotechnology and life sciences, the potential in agricultural applications, and the application in model organisms.
In the coming years, the market for genome editing/engineering is projected to experience rapid expansion. The market is forecasted to increase to $20.81 billion by 2029, with a compound annual growth rate (CAGR) of 19.5%. Factors contributing to this estimated growth during the forecast period include the rise of prime editing, attention on moral and regulatory structures, increased use in drug discovery, the therapeutic potential for genetic disorders, customization for gene function investigations, and a heightened interest in epigenome editing. Key trends predicted for this period consist of advancements in Crispr technology, broadening uses in therapeutics, the introduction of new genome editing tools, investments and collaborations, improved delivery systems, and the incorporation of artificial intelligence (AI) in genome editing design.
What Factors Are Propelling the Growth of the genome editing/genome engineering Market from 2025 to 2034?
The increase in cases of cancer and other genetic diseases is poised to drive the expansion of the genome editing/engineering market. Cancer refers to diseases in which some of the body’s cells multiply uncontrollably and spread to other parts of the body. Genome editing has the ability to rapidly modify immune cells and oncolytic viruses for use in cancer treatments. For example, in February 2022, the World Health Organization (WHO), a Swiss United Nations health agency, published an article stating that approximately 10 million deaths, or nearly one in six worldwide, were attributed to cancer, marking it as the primary cause of death globally. Moreover, in June 2022, the Centers for Disease Control and Prevention (CDC), a United States national public health agency, published a report detailing 1,752,735 new incidences of invasive cancer, including 863,830 women and 888,905 men, reported in the US in 2019. The rate of all cancer incidences stood at 439 per 100,000 people across the general population. As such, the growing prevalence of cancer and genetic diseases is fueling the expansion of the genome editing and genome engineering market.
Explore Comprehensive Insights Into The Global Genome Editing/Genome Engineering Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp
Who Are the Leading Companies Pioneering Change in the Genome Editing/Genome Engineering Market?
Major companies operating in the genome editing/genome engineering market are:
• Thermo Fisher Scientific Inc._x000D_
• Merck Group_x000D_
• Genscript Biotech Corp_x000D_
• Sangamo Therapeutics Inc._x000D_
• Lonza Group AG_x000D_
What Are the Most Significant Trends Transforming the Genome Editing/Genome Engineering Market Today?
Gene editing tech advancements are a notable trend picking up pace in the genome editing/genome engineering space. Many leading companies in this market are putting emphasis on carving out innovative tech solutions to enhance their standing. Take for example, in May 2022, Kyoto University along with Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), a research university in Spain specialising in evolutionary biology, revealed an efficient and swift gene editing procedure for insects. This method, termed as Direct parental CRISPR (DIPA-CRISPR), involves the injection of materials into growing eggs in female adults as opposed to embryos. This groundbreaking method allows researchers to bypass microinjecting CRISPR material into insect embryos.
Secure Your Global Genome Editing/Genome Engineering Market Report Now for Fast and Efficient Delivery!
Which Market Segments Are Driving Strategic Growth and Trends in the Genome Editing/Genome Engineering Market?
The genome editing/genome engineering market covered in this report is segmented –
1) By Product And Service: Reagents And Consumables, Software And systems, Services
2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies
3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications
4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes
Subsegments:
1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents
2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems
3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects
Which Regions Are Leading the Charge in Genome Editing/Genome Engineering Market Development?
North America was the largest region in the gene editing/genome engineering market in 2024. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Definition of the Genome Editing/Genome Engineering Market Impacting Future Growth?
Genome editing is a technique that enables scientists to alter the DNA of numerous organisms, including plants, bacteria, and animals. With the help of genome editing technologies, researchers would alter DNA, changing physical characteristics like eye color and the risk of contracting diseases. Genome editing is used in animal models and cells in research labs to understand diseases.
Browse Through More Similar Reports By The Business Research Company:
Gene Editing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report
Cell and Gene Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report
CRISPR Technology Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/crispr-technology-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
